| GoMiner: a resource for biological interpretation of genomic and proteomic data BR Zeeberg, W Feng, G Wang, MD Wang, AT Fojo, M Sunshine, ... Genome biology 4 (4), 1-8, 2003 | 1454 | 2003 |
| Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells G Szakács, JP Annereau, S Lababidi, U Shankavaram, A Arciello, ... Cancer cell 6 (2), 129-137, 2004 | 678 | 2004 |
| Comprehensive pan-genomic characterization of adrenocortical carcinoma S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ... Cancer cell 29 (5), 723-736, 2016 | 660 | 2016 |
| Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays S Nishizuka, L Charboneau, L Young, S Major, WC Reinhold, M Waltham, ... Proceedings of the National Academy of Sciences 100 (24), 14229-14234, 2003 | 568 | 2003 |
| Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance Y Huang, P Anderle, KJ Bussey, C Barbacioru, U Shankavaram, Z Dai, ... Cancer research 64 (12), 4294-4301, 2004 | 362 | 2004 |
| Karyotypic complexity of the NCI-60 drug-screening panel AV Roschke, G Tonon, KS Gehlhaus, N McTyre, KJ Bussey, S Lababidi, ... Cancer research 63 (24), 8634-8647, 2003 | 340 | 2003 |
| Diagnostic markers that distinguish colon and ovarian adenocarcinomas: identification by genomic, proteomic, and tissue array profiling S Nishizuka, ST Chen, FG Gwadry, J Alexander, SM Major, U Scherf, ... Cancer research 63 (17), 5243-5250, 2003 | 262 | 2003 |
| Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel KJ Bussey, K Chin, S Lababidi, M Reimers, WC Reinhold, WL Kuo, ... Molecular cancer therapeutics 5 (4), 853-867, 2006 | 195 | 2006 |
| MatchMiner: a tool for batch navigation among gene and gene product identifiers KJ Bussey, D Kane, M Sunshine, S Narasimhan, S Nishizuka, ... Genome biology 4 (4), 1-7, 2003 | 189 | 2003 |
| Chromosome abnormalities of eighty‐one pediatric germ cell tumors: Sex‐, age‐, site‐, and histopathology‐related differences—a Children's Cancer Group study KJ Bussey, HJ Lawce, SB Olson, DC Arthur, DK Kalousek, M Krailo, ... Genes, Chromosomes and Cancer 25 (2), 134-146, 1999 | 183 | 1999 |
| Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells PL Lorenzi, WC Reinhold, M Rudelius, M Gunsior, U Shankavaram, ... Molecular cancer therapeutics 5 (11), 2613-2623, 2006 | 141 | 2006 |
| Mistaken identifiers: gene name errors can be introduced inadvertently when using Excel in bioinformatics BR Zeeberg, J Riss, DW Kane, KJ Bussey, E Uchio, WM Linehan, ... BMC bioinformatics 5 (1), 1-6, 2004 | 133 | 2004 |
| Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells JK Lee, KJ Bussey, FG Gwadry, W Reinhold, G Riddick, SL Pelletier, ... Genome biology 4 (12), 1-12, 2003 | 132 | 2003 |
| Multifactorial regulation of E-cadherin expression: an integrative study WC Reinhold, MA Reimers, P Lorenzi, J Ho, UT Shankavaram, ... Molecular cancer therapeutics 9 (1), 1-16, 2010 | 90 | 2010 |
| Isotropic 3D nuclear morphometry of normal, fibrocystic and malignant breast epithelial cells reveals new structural alterations V Nandakumar, L Kelbauskas, KF Hernandez, KM Lintecum, P Senechal, ... PloS one 7 (1), e29230, 2012 | 79 | 2012 |
| Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4–ALK translocation as a therapeutic target MJ Demeure, M Aziz, R Rosenberg, SD Gurley, KJ Bussey, JD Carpten World Journal of Surgery 38, 1296-1305, 2014 | 70 | 2014 |
| Ancestral gene regulatory networks drive cancer KJ Bussey, LH Cisneros, CH Lineweaver, PCW Davies Proceedings of the National Academy of Sciences 114 (24), 6160-6162, 2017 | 69 | 2017 |
| SNRPN methylation patterns in germ cell tumors as a reflection of primordial germ cell development KJ Bussey, HJ Lawce, E Himoe, XO Shu, NA Heerema, EJ Perlman, ... Genes, Chromosomes and Cancer 32 (4), 342-352, 2001 | 68 | 2001 |
| PTTG1 overexpression in adrenocortical cancer is associated with poor survival and represents a potential therapeutic target MJ Demeure, KE Coan, CS Grant, RA Komorowski, E Stephan, S Sinari, ... Surgery 154 (6), 1405-1416, 2013 | 66 | 2013 |
| Ancient genes establish stress-induced mutation as a hallmark of cancer L Cisneros, KJ Bussey, AJ Orr, M Miočević, CH Lineweaver, P Davies PLoS One 12 (4), e0176258, 2017 | 61 | 2017 |
John N WeinsteinMD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
